-

Pharmatech Promotes Mustafa Abdallah to Executive Leadership Role

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates today announced the promotion of Mustafa Abdallah to the position of vice president, regulatory compliance, from his previous role as director. Mr. Abdallah works with a broad array of life science organizations, drug and device sponsors, and contract manufacturing solution providers.

“Pharmatech has assembled one of the most diverse professional teams in the industry, and I am particularly pleased when our associates produce results leading to promotion to our Executive Leadership Team,” said Warren Baker, chief executive officer, Pharmatech Associates. “Mustafa’s outstanding personal character, technical excellence, and influential leadership qualities embody the very definition of a trusted advisor, dedicated to solving the global regulatory problems our clients face.”

Mr. Abdallah brings over 20 years of experience in computer systems validation (CSV), design and deployment of quality management systems (QMS), IT operations and financial security systems within regulated life sciences environments. He holds a bachelor of science in analytical chemistry from California State University, Fresno, and a MBA from California State University, East Bay.

About Pharmatech Associates

Pharmatech Associates is a global consultancy for the life science industry, meeting the complex needs of clients with highly experienced scientists and engineering subject matter experts. Pharmatech’s team specializes in Product and Process Development, Facilities and Capital Projects, Regulatory Compliance, and Regulatory Affairs. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe and North America from its headquarters in the San Francisco Bay Area. https://pharmatechassociates.com/

Contacts

Judy Curtis—SIPR for Pharmatech
+ 1 650-274-1509
judy@sipr.com

More News From Pharmatech Associates

Pharmatech Associates Adds Biotech Leader Praveen Tyle, Ph.D. to Board of Trustees

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates, global pharma manufacturing consultancy owned by USP, adds biotech leader Dr. Praveen Tyle to its board of trustees...

Pharmatech Associates Showcases Strategic Program Development for Drug Sponsors and Innovators at CPHI Barcelona 2023

BARCELONA, Spain & HAYWARD, Calif.--(BUSINESS WIRE)--At CPHI Barcelona, Pharmatech Associates presents how it helps drug sponsors and pharma companies with quality, regulatory, and US market entry...

Pharmatech Associates’ Board of Directors Appoints Sireesha Yadlapalli as Chief Executive Officer

HAYWARD, Calif.--(BUSINESS WIRE)--The Board of Directors of Pharmatech Associates today announced the appointment of Sireesha Yadlapalli as chief executive officer, effective June 5, 2023. Ms. Yadlapalli will succeed Bikash Chatterjee, who will remain with the organization as President and chief science officer. Yadlapalli brings industry and regulatory experience to Pharmatech gained during her over 20-year career in the biopharmaceutical industry in positions in finance, business development,...
Back to Newsroom